US3074406A - Surgical sponges - Google Patents
Surgical sponges Download PDFInfo
- Publication number
- US3074406A US3074406A US820612A US82061259A US3074406A US 3074406 A US3074406 A US 3074406A US 820612 A US820612 A US 820612A US 82061259 A US82061259 A US 82061259A US 3074406 A US3074406 A US 3074406A
- Authority
- US
- United States
- Prior art keywords
- radioactive
- sponge
- sponges
- labeling agent
- surgical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
- A61B6/12—Devices for detecting or locating foreign bodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/44—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators with radio-opaque material or signalling means for residual material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
- A61B2090/392—Radioactive markers
Definitions
- lt is the object ot this invention to overcome the deliciencies of the art by the provision of surgical Sponges having affine thereto with suilicient permanence to resist leaching by the body fluids, a non-toxic quantity of a radioactive labeling agent sufdcient to render the labeled sponge easily detectable by conventional scintillation counters.
- the labeled Sponges are prepared by contacting pieces of absorbent material of suitable size to be useful as surgical Sponges, with a radioactive labeling agent, and subjecting them to conditions of heat and pressure for a time su'icient to assure sterilization.
- the single step of autoclaving the impregnated sponge until it is sterilized yields, not only a sponge Which is surgically sterile, but one which contains a labeling agent ailhred With such permanence that it remains aixed to the sponge even in the presence of body fluids in which the labeling agents per se are soluble.
- the sterilized labeled sponge thus prepared can be used in the manner prescribed for ordinary unlabeled surgical Sponges.
- the absorbent material suitable for use herein can be any substance which is normally used as a surgical sponge. Cotton gauge pads, being readily available and highly economical, are preferred.
- the labeling agents suitable for the practice of this invent-ion must contain, preferably in chemically combined form, a metallic or non-metallic radioactive isotope which is non-toxic in quantities which are suieiently radioactive lto percepti'oly register on conventional crystal scintillation counting equipment. Thus, in the proper amount, it must be able to register a count which is at least two, and optimally at least rive times the count being continually registered by the ambient radiation normally existing in the atmospheric background.
- Preferred isotopes are those which have a hall life greater than one Week and less than two months and emit primarily gamice .ma radiation.
- the isotopes may form, or be a part of, either the anion or the cation of the compound which constitutes the labeling agent.
- the isotope may be chemically combined as a simple ion resulting from the loss or gain of electrons, or in the form of a complex ion such as the chromate ion.
- radioactive isotopes may be mentioned inter alia: radioactive halogens such -as 1131; radioactive alkaline earth metals such as Bali0 and Ca47; radioactive alkali metals such as Rb; and radioactive heavy metals such as those of the iron period (e0. Cr51, Mnz, 21165 and Fe59); and those of the silver period (eg. Ag105, Agl6 and Cd115).
- the labeling agent is most conveniently applied to the surgical sponge in the form of a dilute solution of the radioactive chemical compound in a liquid medium.
- the liquid medium may be chosen from a Wide range of organic solvents and inorganic solvent which will dissolve the radioactive compound to be used as the labeling agent.
- useful solvent it is preferred as the liquid medium for Water soluble labeling agents.
- To prepare the solution it is only necessary to dissolve the radioactive material in the Water. This may in most cases be accomplished at room temperatures, but may be hastened in others by the application of heat.
- radioactive isotopes there may be named *sodium chromate (it indicates the radioactive moiety), *calcium iodide, *barium carbonate, zinc "chloride, ferrous ilsulfate, ferric itchloride, cadmium *sulfate and silver *nitrate
- concentration of the radioactive material in the solution will depend on the amount of solution to be used in treating each sponge. Suliicient solution should be used for each sponge to assure that the sponge will be suiiiciently radioactive to register a count of at least twice, and optimally etween live and ten times the background count on a crystal scintillation counter.
- a conventional sponge is treated with a quantity of a solution of the radioactive labeling agent, as defined above.
- the labeling agent is then aixed to the sponge by subjecting it to heat and/ or pressure (eg. autoclaving) for a time sufficient to at least sterilize the sponge.
- heat and/ or pressure eg. autoclaving
- Conventional hospital autoclaving equipment is suitable for the performance of this step. Suitable results are obtained by heating the sponge at 250 F. and l5 p.s.i. for a period of l5 minutes. rl ⁇ e1riperature, pressure and length of heating step may be varied so long as the selected conditions will yield properly sterilized Sponges.
- the Sponges thus produced are used as the conventional unlabeled Sponges. They should be used within a short period following preparation in order to insure that decay of the labeling agent does not proceed to the point at Which the labeled Sponges are not suticiently radioactive to energize the conventional crystal scintillation counting equipment which is to be used to locate the sponge.
- the Sponges may be discarded through the usual radioactive Waste disposal facilities.
- EXAMPLE A Preparation of Sodium Chromate Solution
- a glass vessel containing dilute solution of chromic chloride (l0 ml.) having a speciiic activity of l0 millicuries/mg. is immersed in an ice-salt water bath and chilled to below 4 C. 2 N.
- sodium hydroxide is added to the chilled solution dropwise, with stirring until a light blue opalescent precipitate appears.
- the dropwise Since Water is the most readily available yand addition is continued until the precipitate dissolves.
- Hydrogen peroxide (30%) is added dropwise until the light blue-green color changes .to yellow and the solution is removed from the Water bath and boiled to remove the B.
- Preparation of Labeled Surgical Sponges A( conventional cotton gauze surgical sponge measuring Z n 2" is treated with 0.1 ml.y of the solution prepared in step A.
- the treated sponge I is Wrapped in absorbent paper and placed in an autoclave which is adjust'edY to maintain a pressure of 15 p.s.i. at ⁇ a temperature of 250 F.
- the spongeY is removed from the autoclave and tested for specific activity. It shows a radio# activity'of 1.2 microcuries.
- a sponge prepared as in step B was implanted in a large dog.
- the sponge exhibited sucient radioactivity to be easily detectable by a conventional crystal scintillation counter.
- the urine of the dog tested negative 24 hours for radioactive material, and gross lscintilla- 'tion scanningv of ⁇ the animal .indicated no translocation of radioactivity throughout the animal. The tests show that the radioactive moiety had been permanently fixed to the sponge by autoclaving.
- a process of preparing a surgical sponge having a radioactive labeling agent permanently affixed thereto and impregnated thereon which comprises treating an absorbent material wvith a solution of a radioactive labeling ⁇ agent until a non-toxic quantity of said agent is absorbed and then heating the absorbent material for a time and under conditions Sucient to permanently aix the radioactive labeling agent to the absorbent material'and to assure sterilization,
- a process'of aixing a radioactive labeling Yagent to a ⁇ surgical sponge vwhich comprises treating a surgical cotton sponge with a solution of a radioactive labeling agent until 4a non-toxic quantity of said agent is absorbed on said sponge and then autoclaving the sponge for a time suiicient to permanently Aaiiix the radioactive labeling agent to the sponge and to assure sterilization of the sponge.
Description
United States Patent() 3,974,496 SRGCAL SFNGES Fatti Nuineio, ighland Park, and Gordon Lindenhlad, Township, Nd., assignors to @lin Mathieson Chemical orporation, New York, NX., a corporation oi Virginia No Brewing. Filed June 16, i959, Ser. No. Silul 3 Claims. till. l--d) This invention relates to improved surgical Sponges and the preparation thereof.
The location and recovery of surgical Sponges (i.e., sterile pads of absorbent material used to absorb body iluids which tend to collect and thus interfere With the erformance of successful operative procedures) is a problem which is as old as the operative procedures themselves. The problem is made more difficult by the tendency of the Sponges to become camoul'laged through absorption o the colored body fluids thereby diminishing the usefulness of the visual faculties in detecting them. Attempts have been made to solve the problem by maintaining a careful count of the Sponges that are used and comparing it with the count of the Sponges which are discarded. 1further attempts at solution have been made by using metal-wired sponges which can be located by X-ray. Neither the tally method, nor the X-ray method has been an ideal solution since in the case of the former human fraility often leads to improper counts, and in the case of the latter, the use of X-rays results in unwanted delays towards tne completion of operative procedures While awaiting the developed X-ray pictures, and necessitates the presence in the operating room of the cumbersome and expensive X-ray equipment.
lt is the object ot this invention to overcome the deliciencies of the art by the provision of surgical Sponges having affine thereto with suilicient permanence to resist leaching by the body fluids, a non-toxic quantity of a radioactive labeling agent sufdcient to render the labeled sponge easily detectable by conventional scintillation counters.
ln accordance With the method of this invention, the labeled Sponges are prepared by contacting pieces of absorbent material of suitable size to be useful as surgical Sponges, with a radioactive labeling agent, and subjecting them to conditions of heat and pressure for a time su'icient to assure sterilization.
Unexpectedly it has been found that the single step of autoclaving the impregnated sponge until it is sterilized yields, not only a sponge Which is surgically sterile, but one which contains a labeling agent ailhred With such permanence that it remains aixed to the sponge even in the presence of body fluids in which the labeling agents per se are soluble. The sterilized labeled sponge thus prepared can be used in the manner prescribed for ordinary unlabeled surgical Sponges.
The absorbent material suitable for use herein can be any substance which is normally used as a surgical sponge. Cotton gauge pads, being readily available and highly economical, are preferred.
The labeling agents suitable for the practice of this invent-ion must contain, preferably in chemically combined form, a metallic or non-metallic radioactive isotope which is non-toxic in quantities which are suieiently radioactive lto percepti'oly register on conventional crystal scintillation counting equipment. Thus, in the proper amount, it must be able to register a count which is at least two, and optimally at least rive times the count being continually registered by the ambient radiation normally existing in the atmospheric background. Preferred isotopes are those which have a hall life greater than one Week and less than two months and emit primarily gamice .ma radiation. The isotopes may form, or be a part of, either the anion or the cation of the compound which constitutes the labeling agent. The isotope may be chemically combined as a simple ion resulting from the loss or gain of electrons, or in the form of a complex ion such as the chromate ion. Among the preferred radioactive isotopes may be mentioned inter alia: radioactive halogens such -as 1131; radioactive alkaline earth metals such as Bali0 and Ca47; radioactive alkali metals such as Rb; and radioactive heavy metals such as those of the iron period (e0. Cr51, Mnz, 21165 and Fe59); and those of the silver period (eg. Ag105, Agl6 and Cd115).
The labeling agent is most conveniently applied to the surgical sponge in the form of a dilute solution of the radioactive chemical compound in a liquid medium. The liquid medium may be chosen from a Wide range of organic solvents and inorganic solvent which will dissolve the radioactive compound to be used as the labeling agent. useful solvent it is preferred as the liquid medium for Water soluble labeling agents. To prepare the solution it is only necessary to dissolve the radioactive material in the Water. This may in most cases be accomplished at room temperatures, but may be hastened in others by the application of heat. Among the labeling agents Which may be formed with the foregoing radioactive isotopes there may be named *sodium chromate (it indicates the radioactive moiety), *calcium iodide, *barium carbonate, zinc "chloride, ferrous ilsulfate, ferric itchloride, cadmium *sulfate and silver *nitrate The proper concentration of the radioactive material in the solution will depend on the amount of solution to be used in treating each sponge. Suliicient solution should be used for each sponge to assure that the sponge will be suiiiciently radioactive to register a count of at least twice, and optimally etween live and ten times the background count on a crystal scintillation counter.
In order to prepare the labeled surgical Sponges of this invention a conventional sponge is treated with a quantity of a solution of the radioactive labeling agent, as defined above. The labeling agent is then aixed to the sponge by subjecting it to heat and/ or pressure (eg. autoclaving) for a time sufficient to at least sterilize the sponge. Conventional hospital autoclaving equipment is suitable for the performance of this step. Suitable results are obtained by heating the sponge at 250 F. and l5 p.s.i. for a period of l5 minutes. rl`e1riperature, pressure and length of heating step may be varied so long as the selected conditions will yield properly sterilized Sponges.
The Sponges thus produced are used as the conventional unlabeled Sponges. They should be used Within a short period following preparation in order to insure that decay of the labeling agent does not proceed to the point at Which the labeled Sponges are not suticiently radioactive to energize the conventional crystal scintillation counting equipment which is to be used to locate the sponge.
Aft-er use, the Sponges may be discarded through the usual radioactive Waste disposal facilities.
The following example is presented to more fully illustrate the invention.
EXAMPLE A. Preparation of Sodium Chromate Solution A glass vessel containing dilute solution of chromic chloride (l0 ml.) having a speciiic activity of l0 millicuries/mg. is immersed in an ice-salt water bath and chilled to below 4 C. 2 N. sodium hydroxide is added to the chilled solution dropwise, with stirring until a light blue opalescent precipitate appears. The dropwise Since Water is the most readily available yand addition is continued until the precipitate dissolves. Hydrogen peroxide (30%) is added dropwise until the light blue-green color changes .to yellow and the solution is removed from the Water bath and boiled to remove the B. Preparation of Labeled Surgical Sponges A( conventional cotton gauze surgical sponge measuring Z n 2" is treated with 0.1 ml.y of the solution prepared in step A. The treated sponge Iis Wrapped in absorbent paper and placed in an autoclave which is adjust'edY to maintain a pressure of 15 p.s.i. at `a temperature of 250 F. The spongeY is removed from the autoclave and tested for specific activity. It shows a radio# activity'of 1.2 microcuries.
In order to show the usefulness of the Sponges of this invention a sponge prepared as in step B was implanted in a large dog. The sponge exhibited sucient radioactivity to be easily detectable by a conventional crystal scintillation counter. lThe urine of the dog tested negative 24 hours for radioactive material, and gross lscintilla- 'tion scanningv of` the animal .indicated no translocation of radioactivity throughout the animal. The tests show that the radioactive moiety had been permanently fixed to the sponge by autoclaving.
Eollov'ving the exemplied procedure, surgical sponges l. A process of preparing a surgical sponge having a radioactive labeling agent permanently affixed thereto and impregnated thereon, which comprises treating an absorbent material wvith a solution of a radioactive labeling `agent until a non-toxic quantity of said agent is absorbed and then heating the absorbent material for a time and under conditions Sucient to permanently aix the radioactive labeling agent to the absorbent material'and to assure sterilization,
2. A process'of aixing a radioactive labeling Yagent to a `surgical sponge, vwhich comprises treating a surgical cotton sponge with a solution of a radioactive labeling agent until 4a non-toxic quantity of said agent is absorbed on said sponge and then autoclaving the sponge for a time suiicient to permanently Aaiiix the radioactive labeling agent to the sponge and to assure sterilization of the sponge.
'3. The process of claim 2 in which the labeling agent is sodium radioactive chromate.
References Cited in the le of this patentV UNITED STATES PATENTS
Claims (1)
1. A PROCESS OF PREPARING A SURGICAL SPONGE HAVING A RADIACTIVE LABELING AGENT PERMANENTLY AFFIXED THERETO AND IMPREGATED THEREON, WHICH COMPRISES TREATING AN ABSORBENT MATERIAL WITH A SOLITION OF A RADIOACTIVE LABELING AGENT UNTIL A NON-TOXIC QUANTITY OF SAID AGENT IS ABSORBED AND THEN HEATING THE ABSORBENY MATERIAL FOR A TIME AND UNDER CONDITIONS SUFFICIENT TO PERMANENTLY AFFIX THE RADIOACTIVE LABELING AGENT TO THE ABSORBENT MATERIAL AND TO ASSURE STERILIZATION.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US820612A US3074406A (en) | 1959-06-16 | 1959-06-16 | Surgical sponges |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US820612A US3074406A (en) | 1959-06-16 | 1959-06-16 | Surgical sponges |
Publications (1)
Publication Number | Publication Date |
---|---|
US3074406A true US3074406A (en) | 1963-01-22 |
Family
ID=25231292
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US820612A Expired - Lifetime US3074406A (en) | 1959-06-16 | 1959-06-16 | Surgical sponges |
Country Status (1)
Country | Link |
---|---|
US (1) | US3074406A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3422816A (en) * | 1964-12-09 | 1969-01-21 | Johnson & Johnson | Surgical dressing |
US4205680A (en) * | 1978-01-13 | 1980-06-03 | Work Wear Corporation, Inc. | Radiopaque laparatomy sponge |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1956948A (en) * | 1932-06-10 | 1934-05-01 | Fattinger Franz | Radioactive artificial fiber |
US2740405A (en) * | 1948-08-04 | 1956-04-03 | Howard C Riordan | Surgical sponge with radioactive tracer |
-
1959
- 1959-06-16 US US820612A patent/US3074406A/en not_active Expired - Lifetime
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1956948A (en) * | 1932-06-10 | 1934-05-01 | Fattinger Franz | Radioactive artificial fiber |
US2740405A (en) * | 1948-08-04 | 1956-04-03 | Howard C Riordan | Surgical sponge with radioactive tracer |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3422816A (en) * | 1964-12-09 | 1969-01-21 | Johnson & Johnson | Surgical dressing |
US4205680A (en) * | 1978-01-13 | 1980-06-03 | Work Wear Corporation, Inc. | Radiopaque laparatomy sponge |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Fleming et al. | Photoscanning of bone lesions utilizing strontium 85 | |
Shields et al. | Action of aldosterone upon the intestinal transport of potassium, sodium, and water. | |
Veall et al. | The preparation of 132I and 131I labelled human serum albumin for clinical tracer studies | |
US3074406A (en) | Surgical sponges | |
US3664964A (en) | Eluent for radioisotopes | |
Pochin et al. | The effect of pharmacological doses of non-radioactive iodide on the course of radioiodine uptake by the thyroid | |
US2190431A (en) | X-ray opaque sponge | |
Dunson et al. | Preparation and comparison of technetium-99m diphosphonate, polyphosphate and pyrophosphate nuclear bone imaging radiopharmaceuticals | |
Lincoln et al. | Radiation doses in diagnostic x-ray procedures | |
Balls et al. | The treatment of thyrotoxicosis with radioiodine | |
Herbert et al. | Metabolic behavior and radiation dosimetry of 99mTc-albumin in pregnancy | |
Lambrecht et al. | Kit for Carrier-Free 123I-Sodium Iodide. VIII | |
Taft | Demonstration of gamma radiation from living patient following thorotrast injection | |
Browning et al. | Airborne concentration of I-131 in a nuclear medicine laboratory | |
Brucer | Radioisotope hazards and protection in a hospital | |
Morgan | Ionizing radiation: Benefits versus risks | |
GB1453291A (en) | Radiactive generator with permeable closure | |
Brodsky et al. | Experiences with early emergency response and rules of thumb | |
Johnson et al. | Initial Evaluation of Indium 113m as an Agent for Placental Blood Pool Imaqinq | |
Cutler | The radium treatment of cancer | |
Laughlin et al. | Exposure of embalmers and physicians by radioactive cadavers | |
Saenger | Planning for a radiation accident | |
Basson et al. | Health physics evaluation of an accident involving acute overexposure to a radiography source | |
World Health Organization | Manual on early medical treatment of possible radiation injury with an appendix on sodium burns | |
Kim | Diagnostic and therapeutic management of acute radiation syndrome and internal contamination |